Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A 2 inhibitors

Author： Fox N.   Min S.   Schrementi J.   Sharp J.D.   White D.L.   Snyder D.W.   Hartley L.W.   Carlson D.G.   Bach N.J.   Dillard R.D.   Draheim S.E.   Bobbitt J.L.   Fisher L.   Mihelich E.D.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.308, Iss.2, 1996-07, pp. : 195-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A molecular modeling and 3D QSAR study of a large series of indole inhibitors of human non-pancreatic secretory phospholipase A 2

By Bernard P.   Pintore M.   Berthon J.-Y.   Chretien J.R.  

European Journal of Medicinal Chemistry, Vol. 36, Iss. 1, 2001-01 ,pp. : 1-19

Elsevier

Access to resources Recommend Favorite

Inhibitors of Secretory Phospholipase A2 Group IIA

By  

Current Medicinal Chemistry, Vol. 12, Iss. 25, 2005-12 ,pp. : 3011-3026

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Dual Inhibitors of Secretory Phospholipase A2 and Sphingomyelin Synthase: Design, Synthesis and Evaluation

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 10, 2016-12 ,pp. : 1025-1032

Bentham Science Publishers

Access to resources Recommend Favorite

Protein-based alignment in 3D QSAR of 26 indole inhibitors of human pancreatic phospholipase A 2

By Pintore M.   Bernard P.   Berthon J.-Y.   Chretien J.R.  

European Journal of Medicinal Chemistry, Vol. 36, Iss. 1, 2001-01 ,pp. : 21-30

Elsevier

Access to resources Recommend Favorite

A Concise Update on the Relevance of Secretory Phospholipase A2 Group IIA and its Inhibitors with Cancer

By  

Medicinal Chemistry, Vol. 13, Iss. 7, 2017-10 ,pp. : 606-615

Bentham Science Publishers

Access to resources Recommend Favorite